Cardiac Side Effects of Intravenous Magnesium
Intravenous magnesium causes dose-dependent cardiac depression, with the most clinically significant effects being hypotension, bradycardia, and at toxic levels (>10 mEq/L), complete heart block and cardiac arrest. 1, 2
Mechanism of Cardiac Effects
Magnesium acts as a vasodilator and depresses cardiac conduction by blocking neuromuscular transmission and decreasing acetylcholine release at the motor end-plate. 2 It also affects the movement of sodium, potassium, and calcium across cell membranes, stabilizing excitable membranes. 1
Dose-Dependent Cardiac Manifestations
Therapeutic Range (1.5-2.5 mEq/L)
- Minimal cardiac effects when magnesium is within normal plasma levels 2
- Transient flushing and mild vasodilation may occur with rapid administration 2, 3
Low-Dose Effects (2.5-4 mEq/L)
- Flushing and sweating are the primary manifestations 2
- Mild hypotension due to peripheral vasodilation 1, 2
- These effects are rate-dependent and can be minimized by infusing over ≥15 minutes 4
Moderate Elevation (4-10 mEq/L)
- Progressive bradycardia develops as levels rise 1, 5
- Hypotension becomes more pronounced 1, 2
- Deep tendon reflexes disappear around 10 mEq/L 2
- Respiratory paralysis may occur at this level 2
- Heart block can develop 1, 2
Severe Toxicity (>10-12 mEq/L)
- Cardiac arrest may occur, with levels >12 mEq/L potentially fatal 1, 2
- Asystole is the terminal rhythm 1
- Circulatory collapse with profound CNS and cardiac depression 2
Clinical Context-Specific Considerations
Emergency Arrhythmia Treatment (Torsades de Pointes)
- 1-2 g IV push over 5 minutes is the standard dose for polymorphic VT with prolonged QT 6, 7
- Up to 4 g may be administered in life-threatening situations 4
- The risk of bradycardia and hypotension is acceptable given the alternative of refractory ventricular arrhythmia 7
Routine Supplementation
- Maximum safe infusion rate is 150 mg/min (approximately 1.5 mL of 10% solution per minute) 4
- Monitor blood pressure and heart rate during and after infusion 4
- For stable patients with low-normal magnesium (≈1.3 mg/dL), 1-2 g IV over 15-60 minutes is appropriate 4
Atrial Fibrillation Rate Control
- When added to digoxin, magnesium reduces ventricular response but is less likely to cause significant bradycardia or AV block compared to calcium antagonists or amiodarone (0% vs 9.2%) 8
- This makes it a safer option in patients at risk for conduction abnormalities 8
Rate-Related Adverse Effects
The speed of administration is the primary determinant of acute cardiovascular side effects. 9, 3
- Rapid bolus administration causes transient flushing, hypotension, and potential AV conduction abnormalities 9, 3
- Slow infusion over 15-60 minutes minimizes these effects while maintaining therapeutic efficacy 4, 3
- In the LIMIT-2 trial, the main side effect was transient flushing related to the speed of the loading dose injection 3
Iatrogenic Overdose Risk
A critical safety concern is the variety of measurement units used in orders and drug labels, which can lead to 10-fold dosing errors. 10
- Two case reports documented patients receiving 20 g instead of 2 g, resulting in cardiac arrest in both cases 10
- One patient was successfully resuscitated and discharged neurologically intact; the other died three days later 10
- Always verify the dose in grams and the concentration of the preparation before administration 10
Reversal of Magnesium Toxicity
Intravenous calcium is the antidote for severe magnesium toxicity. 1
- Calcium chloride (10%) 5-10 mL IV over 2-5 minutes or calcium gluconate (10%) 15-30 mL IV over 2-5 minutes antagonizes the central and peripheral effects of magnesium poisoning 1
- This should be administered immediately in cases of suspected magnesium-induced cardiac arrest 1
Monitoring Parameters
For any patient receiving IV magnesium:
- Continuous cardiac monitoring is essential during administration 5
- Blood pressure monitoring should be performed every 5-15 minutes during infusion 4
- Deep tendon reflexes should be assessed if repeated or high doses are given 2
- Serum magnesium levels should be checked if frequent or prolonged dosing is required, particularly in patients with impaired renal function 6
Special Populations
Renal Dysfunction
- Magnesium is excreted solely by the kidneys at a rate proportional to plasma concentration and glomerular filtration 2
- Patients with renal impairment are at significantly higher risk for hypermagnesemia and its cardiac complications 5, 10
- Reduce doses and increase monitoring frequency in patients with creatinine clearance <30 mL/min 5